captopril has been researched along with Neoplasms in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L | 1 |
| Cheng, Y; Gao, Y; Jia, L; Lian, S; Liang, H; Lu, Y; Xie, J; Xie, X; Ye, Y; Yu, S; Yu, T; Zhu, Y | 1 |
| Monti, M; Morbidelli, L; Terzuoli, E; Ziche, M | 1 |
| Tofield, A | 1 |
| Gordon, RD; Stowasser, M; Wolley, M | 1 |
| Chou, J; Debanne, SM; Fang, JC; Mishra, P; Simon, DI; Sipahi, I | 1 |
| Nasulewicz, A; Opolski, A | 1 |
| Balkwill, F; Blann, AD; Caine, GJ; Christodoulos, K; Dobbs, N; Ganesan, TS; Gompertz, N; Harris, AL; Jones, PH; Kakkar, AJ; Kumar, S; Talbot, DC; Thavasu, P | 1 |
| Mazur, A; Nasulewicz, A; Opolski, A | 1 |
| Blann, AD; Caine, GJ; Christodoulos, K; Harris, AL; Lip, GY | 1 |
| Diz, DI; Robbins, ME | 1 |
5 review(s) available for captopril and Neoplasms
| Article | Year |
|---|---|
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction | 2015 |
Meta-analysis of randomized controlled trials on effect of angiotensin-converting enzyme inhibitors on cancer risk.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Captopril; Enalapril; Fosinopril; Humans; Lisinopril; Neoplasms; Quinapril; Ramipril; Randomized Controlled Trials as Topic; Tetrahydroisoquinolines | 2011 |
[The role of copper in tumor angiogenesis--clinical implications].
Topics: Animals; Captopril; Copper; Humans; Neoplasms; Neovascularization, Pathologic; Oxidation-Reduction; Trientine; Zinc | 2002 |
Role of copper in tumour angiogenesis--clinical implications.
Topics: Angiogenesis Inhibitors; Animals; Captopril; Chelating Agents; Clinical Trials as Topic; Copper; Humans; Neoplasms; Neovascularization, Pathologic; Zinc | 2004 |
Pathogenic role of the renin-angiotensin system in modulating radiation-induced late effects.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Brain; Captopril; Humans; Inflammation; Kidney; Lung; NADP; Neoplasms; Oxidative Stress; Radiation Injuries; Radiation Pneumonitis; Reactive Oxygen Species; Renin-Angiotensin System; Survivors | 2006 |
1 trial(s) available for captopril and Neoplasms
| Article | Year |
|---|---|
Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Captopril; Dalteparin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fibrinolytic Agents; Humans; Hydroxamic Acids; Injections, Subcutaneous; Lymphocytes; Male; Middle Aged; Neoplasms; Phytohemagglutinins; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
6 other study(ies) available for captopril and Neoplasms
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Captopril; Cell Adhesion; Cell Line, Tumor; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Neoplastic Cells, Circulating; P-Selectin; Platelet Glycoprotein GPIIb-IIIa Complex | 2019 |
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Apoptosis; Captopril; Cattle; Cell Line; Cell Line, Tumor; Coronary Vessels; Doxorubicin; Endothelium; Endothelium, Vascular; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms; Tumor Suppressor Protein p53 | 2013 |
ACE inhibitor reduces radiation injury to myocardium.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Fibrosis; Heart; Myocardium; Neoplasms; Pulmonary Fibrosis; Radiation Injuries; Radiation-Protective Agents; Rats | 2013 |
Reninoma: the importance of renal vein renin ratios for lateralisation and diagnosis.
Topics: Adolescent; Adult; Aldosterone; Antihypertensive Agents; Captopril; Enalaprilat; Female; Humans; Hypertension; Hypokalemia; Kidney Glomerulus; Kidney Neoplasms; Neoplasms; Nephrectomy; Renal Artery; Renal Veins; Renin; Tomography, X-Ray Computed; Ultrasonography, Doppler | 2014 |
Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer.
Topics: Adult; Aged; Angiogenesis Inhibitors; Anticoagulants; Captopril; Dalteparin; Female; Humans; Hydroxamic Acids; Male; Middle Aged; Neoplasms; Neovascularization, Pathologic; P-Selectin; Platelet Activation; Thromboplastin; Vascular Endothelial Growth Factor A | 2005 |